ArticleThe Journal of clinical investigation2022

Concerns about the inverse relationship between baseline HBV DNA and on-treatment hepatocellular carcinoma risk.

Shi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.